Other members of the C-X-C motif chemokine family were found to be upregulated in pancreatic cancer cells after Rintatolimod treatment, like CXCL 1, CXCL2, CXCL3, CXCL8 (IL-8), CXCL11, CXCL14, and CXCL16 (Figure 2). Here, CXCL2 is linked to pancreatic neoplasm.